Tools to Reduce Polypharmacy

Clinics in Geriatric Medicine

Volumn 28, Issue 2, 2012, Pages 323-341

  Gokula, Murthy ^a   Holmes, Holly M ^b  

^a St Luke's Hospital Ohio   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Elderly; Inappropriate medication; Medication management; Polypharmacy

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMITRIPTYLINE PLUS PERPHENAZINE; CARISOPRODOL; CHLORDIAZEPOXIDE; CHLORDIAZEPOXIDE PLUS CLIDINIUM BROMIDE; CHLORZOXAZONE; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; CYCLOBENZAPRINE; DEXTROPROPOXYPHENE; DEXTROPROPOXYPHENE NAPSILATE; DIAZEPAM; DOXEPIN; FLURAZEPAM; HALAZEPAM; INDOMETACIN; LIMBITROL; LORAZEPAM; MEPROBAMATE; METAXALONE; METHOCARBAMOL; NON PRESCRIPTION DRUG; OXAZEPAM; OXYBUTYNIN; PENTAZOCINE; QUAZEPAM; TEMAZEPAM; TRIAZOLAM; TRIMETHOBENZAMIDE; UNINDEXED DRUG;

CENTRAL NERVOUS SYSTEM DISEASE; COMORBIDITY; CONFUSION; DECISION SUPPORT SYSTEM; DIET SUPPLEMENTATION; EXTRAPYRAMIDAL SYMPTOM; GERIATRIC PATIENT; HALLUCINATION; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICAL DOCUMENTATION; NURSING HOME; POLYPHARMACY; PRESCRIPTION; REVIEW; SEDATION; SIDE EFFECT; UNITED STATES; UNSPECIFIED SIDE EFFECT; WEAKNESS;

AGED; AGED, 80 AND OVER; DECISION SUPPORT TECHNIQUES; DRUG PRESCRIPTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; POLYPHARMACY; PRACTICE GUIDELINES AS TOPIC;

EID: 84859702198     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2012.01.011     Document Type: Review

References (46)

1. Weiner B.J., Alexander J.A., Shortell S.M., et al. Quality improvement implementation and hospital performance on quality indicators. Health Serv Res 2006, 41(2):307-334.
2. Reason B., Terner M., Moses McKeag A., et al. The impact of polypharmacy on the health of Canadian seniors. Family Pract 2012, [Epub ahead of print].
3. Richardson K., Ananou A., Lafortune L., et al. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging 2011, 28(7):547-560.
4. Qato D.M., Alexander G.C., Conti R.M., et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. Jama 2008, 300(24):2867-2878.
5. Routledge P.A., O'Mahony M.S., Woodhouse K.W. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004, 57(2):121-126.
6. Marcum Z.A., Amuan M.E., Hanlon J.T., et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc 2012, 60(1):34-41.
7. Loganathan M., Singh S., Franklin B.D., et al. Interventions to optimise prescribing in care homes: systematic review. Age Ageing 2011, 40(2):150-162.
8. Marcum Z.A., Handler S.M., Wright R., et al. Interventions to improve suboptimal prescribing in nursing homes: A narrative review. Am J Geriatr Pharmacother 2010, 8(3):183-200.
9. Kaur S., Mitchell G., Vitetta L., et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009, 26(12):1013-1028.
10. Beers M.H., Ouslander J.G., Rollingher I., et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991, 151(9):1825-1832.
11. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997, 157(14):1531-1536.
12. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 163(22):2716-2724.
13. Aparasu R.R., Mort J.R. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother 2000, 34(3):338-346.
14. Budnitz D.S., Shehab N., Kegler S.R., et al. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007, 147(11):755-765.
15. Boulkedid R., Abdoul H., Loustau M., et al. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One 2011, 6(6):e20476.
16. Naugler C.T., Brymer C., Stolee P., et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000, 7(2):103-107.
17. McLeod P.J., Huang A.R., Tamblyn R.M., et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997, 156:385-391.
18. Barry P.J., O'Keefe N., O'Connor K.A., et al. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 2006, 31(6):617-626.
19. O'Mahony D., Gallagher P.F. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008, 37(2):138-141.
20. Barry P.J., Gallagher P., Ryan C., et al. START (screening tool to alert doctors to the right treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007, 36(6):632-638.
21. Gallagher P., Ryan C., Byrne S., et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008, 46(2):72-83.
22. Gallagher P., Baeyens J.P., Topinkova E., et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009, 38(5):603-606.
23. Gallagher P.F., O'Connor M.N., O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011, 89(6):845-854.
24. Gallagher P., O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37(6):673-679.
25. Hanlon J.T., Schmader K.E., Samsa G.P., et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992, 45(10):1045-1051.
26. Samsa G.P., Hanlon J.T., Schmader K.E., et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994, 47(8):891-896.
27. Hajjar E.R., Hanlon J.T., Sloane R.J., et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005, 53(9):1518-1523.
28. Schmader K.E., Hanlon J.T., Landsman P.B., et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997, 31(5):529-533.
29. Wehling M. Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly?. Proposal of a new drug classification: fit for the aged. J Am Geriatr Soc 2009, 57(3):560-561.
30. Frohnhofen H., Michalek C., Wehling M. Assessment of drug treatment in geriatrics with the new FORTA criteria. Dtsch Med Wochenschr 2011, 136(27):1417-1421.
31. Haque R. ARMOR: a tool to evaluate polypharmacy in elderly persons. Annals of Long-Term Care 2009, 17(6):26-30. Accessed January 28, 2012. http://www.annalsoflongtermcare.com/content/armor-a-tool-evaluate-polypharmacy-elderly-persons.
32. Garfinkel D., Zur-Gil S., Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007, 9(6):430-434.
33. Garfinkel D., Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010, 170(18):1648-1654.
34. Olsson I.N., Curman B., Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf 2010, 19(2):150-157.
35. Lapane K.L., Hughes C.M., Daiello L.A., et al. Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. J Am Geriatr Soc 2011, 59(7):1238-1245.
36. Drenth-van Maanen A.C., van Marum R.J., Knol W., et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging 2009, 26(8):687-701.
37. Rudolph J.L., Salow M.J., Angelini M.C., et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008, 168(5):508-513.
38. Lowry E., Woodman R.J., Soiza R.L., et al. Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc 2011, 12(8):565-572.
39. Kumpula E.K., Bell J.S., Soini H., et al. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol 2011, 51(2):256-263.
40. Hilmer S.N., Mager D.E., Simonsick E.M., et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007, 167(8):781-787.
41. Hilmer S.N., Mager D.E., Simonsick E.M., et al. Drug burden index score and functional decline in older people. Am J Med 2009, 122(12):1142-1149. e1141-1142.
42. Gnjidic D., Cumming R.G., Le Couteur D.G., et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009, 68(1):97-105.
43. Lowry E., Woodman R.J., Soiza R.L., et al. Drug Burden Index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol 2011, [Epub ahead of print].
44. Wilson N.M., Hilmer S.N., March L.M., et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011, 59(5):875-880.
45. Wilson N.M., Hilmer S.N., March L.M., et al. Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing 2010, 39(4):503-507.
46. Holt S., Schmiedl S., Thurmann P.A. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010, 107(31-32):543-551.